An Open-label Study (OLE) for Non-responders of VRDN-001-101 and VRDN-001-301

Clinical trial NCT06179875 · COMPLETED

Trial details

NCT number: NCT06179875
Sponsor: Viridian Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Thyroid Eye Disease

Start date: 2024-01-31
Primary completion: 2025-04-25
Enrollment: 139

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.